According to a new report by Polaris Market Research, the global AI in Oncology market was valued at USD 6.51 billion in 2025 and is projected to reach USD 56.44 billion by 2034, expanding at a CAGR of 27.1% over the forecast period. Growth is underpinned by rising demand for precision oncology, expanding use of AI-powered medical imaging, and accelerating adoption of predictive analytics and clinical decision-support tools across cancer care settings worldwide 

What Is Driving AI in Oncology Market Growth?

Demand is climbing as the growing global cancer burden converges with persistent shortages of oncology specialists, pushing hospitals and diagnostic labs toward AI-assisted screening, imaging analysis, and treatment planning. Software-based clinical decision support is emerging as the largest revenue contributor, while AI-enabled imaging and predictive-analytics tools are posting some of the fastest incremental gains as providers look to shorten diagnosis timelines and personalize therapy. Polaris analysts note that the convergence of deep learning with genomic and pathology data is positioning the sector for sustained double-digit growth through 2034, even as data-privacy rules and the availability of high-quality clinical datasets remain key constraints on the pace of adoption.

Key Trends Shaping the AI in Oncology Industry

AI-Enabled Imaging and Diagnostic Innovation

Vendors are embedding deep-learning models directly into radiology, pathology, and endoscopy workflows to flag suspicious lesions faster and with greater consistency than manual review alone, improving both technology advancement and early-detection rates across breast, lung, and brain cancers.

Tightening Data Privacy and Regulatory Oversight

As AI tools move closer to diagnosis and treatment decisions, regulators are sharpening requirements around clinical validation, explainability, and patient-data protection, shaping how vendors design and market new oncology algorithms and reinforcing the broader regulatory landscape for health AI.

Consolidation and Strategic Investment Activity

Established imaging and technology majors are acquiring or partnering with specialized oncology-AI start-ups to round out their portfolios, while national research initiatives are funding platforms that predict drug-candidate success ahead of costly clinical trials, reshaping the competitive landscape and near-term market outlook.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/ai-in-oncology-market 

Market Segmentation: Breaking Down the AI in Oncology Market

Polaris segments the AI in Oncology market by component, cancer type, treatment type, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Component

The software solutions segment led the market in 2025, accounting for 71.5% of revenue, on the strength of growing utilization of AI-powered software for diagnosis, treatment planning, and clinical decision support. The hardware and services segments are expected to expand steadily as healthcare systems scale up their AI infrastructure and integration needs.

By Cancer Type

The breast cancer segment led the market in 2025, accounting for 31.9% of revenue, on the strength of rising global incidence and growing adoption of AI-assisted screening. The brain tumor segment is projected to expand at the fastest rate through 2034 as deep-learning models speed up intraoperative diagnosis and improve differentiation between tumor and healthy tissue.

By Treatment Type

The chemotherapy segment led the market in 2025, accounting for 36.7% of revenue, on the strength of AI-driven dosage personalization that reduces side effects and improves outcomes. The immunotherapy segment is projected to expand at the fastest rate through 2034 as AI-based biomarkers improve prediction of patient response.

Regional Outlook: Where Is AI in Oncology Growing Fastest?

North America led the market in 2025 on the back of well-established digital health infrastructure, favorable reimbursement policies, and a dense concentration of AI and oncology solution providers, while Asia Pacific is expected to post the fastest CAGR of 32.4% through 2034, driven by rapid digitalization of diagnostic labs and hospitals and rising cancer prevalence. Within North America, the U.S. remains the largest single market; within Asia Pacific, China and India are emerging as primary growth engines. Europe rounds out the top three, supported by strong public and private R&D investment in oncology AI.

Competitive Landscape: Leading AI in Oncology Companies

Key players profiled in the report include:

Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI.

These companies are focusing on partnerships, platform expansion, and regulatory clearances to strengthen their position across the software solutions and breast cancer segments outlined above. Recent moves include national research initiatives aimed at applying AI to predict drug-candidate success earlier in the development pipeline, alongside continued product launches targeting imaging-based diagnosis and personalized treatment planning.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the AI in oncology opportunity, this report benchmarks market share, segment-level pricing, and forecast data — by component, cancer type, treatment type, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing AI diagnostic vendors, investors sizing entry points in precision oncology, and strategy teams tracking genomic-analytics integration as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Artificial Intelligence in Manufacturing Market

Rain Barrels Market

Wearable Breast Pumps Market

Sacral Nerve Stimulation Market

Backhoe Loaders Market

Backhoe Loaders Market

Graphite Market

Reclaimed Rubber from Devulcanization Market

Surgical Suction Instruments Market